CG Oncology Inc.(CGON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CGON CG Oncology Inc.

Closed 07-24 16:00:00 EDT

69.32

-1.80

-2.53%

盘后69.32

+0.000.00%

19:34 EDT

High71.02	Low68.96	Vol368.76K
Open71.02	D1 Closing71.12	Amplitude2.90%
Mkt Cap6.10B	Tradable Cap4.56B	Total Shares88.01M
T/O25.64M	T/O Rate0.56%	Tradable Shares65.82M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CGON","market":"US","secType":"STK","nameCN":"CG Oncology Inc.","latestPrice":69.32,"timestamp":1784923200000,"preClose":71.12,"halted":0,"volume":368760,"hourTrading":{"tag":"盘后","latestPrice":69.32,"preClose":69.32,"latestTime":"19:34 EDT","volume":17775,"amount":1232164.68,"timestamp":1784936047020,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.025309336332958537,"floatShares":65824000,"shares":88009980,"eps":-2.352362,"marketStatus":"Closed","change":-1.8,"latestTime":"07-24 16:00:00 EDT","open":71.02,"high":71.02,"low":68.96,"amount":25639646.7936,"amplitude":0.028965,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.352362,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":5,"adr":0,"listingDate":1706158800000,"exchange":"NASDAQ","adjPreClose":71.12,"preHourTrading":{"tag":"盘前","latestPrice":71.12,"preClose":71.12,"latestTime":"09:29 EDT","volume":332,"amount":23837.09702,"timestamp":1784899799915,"change":0,"changeRate":0,"amplitude":0.056243},"postHourTrading":{"tag":"盘后","latestPrice":69.32,"preClose":69.32,"latestTime":"19:34 EDT","volume":17775,"amount":1232164.68,"timestamp":1784936047020,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.408914,"impliedVol":1.003,"impliedVolPercentile":0.8207},"requestUrl":"/m/hq/s/CGON/tweets","defaultTab":"tweets","newsList":[{"id":"2652280730","title":"CG Oncology Director Leonard Post Disposes of 1,000 Shares for $71,170","url":"https://stock-news.laohu8.com/highlight/detail?id=2652280730","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652280730?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:15","pubTimestamp":1784319335,"startTime":"0","endTime":"0","summary":"CG Oncology director Leonard Post disposes of 1,000 shares for $71,170CG Oncology director Leonard E. Post sold 1,000 common shares on July 15 at USD 71.17, cutting his direct stake to zero.Post also ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDL9wLLGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CG Oncology Director Leonard Post Disposes of 1,000 Shares for $71,170","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652209194","title":"Ani Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter","url":"https://stock-news.laohu8.com/highlight/detail?id=2652209194","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652209194?lang=en_us&edition=fundamental","pubTime":"2026-07-17 06:33","pubTimestamp":1784241232,"startTime":"0","endTime":"0","summary":"July 16 (Reuters) - ANI Pharmaceuticals Inc::*ANI PHARMACEUTICALS ANNOUNCES INTENT TO APPEAL RULINGS IN CG ONCOLOGY MATTER*ANI PHARMACEUTICALS - TRIAL COURT DENIES ANI PHARMACEUTICALS' MOTION FOR NEW ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nRSD9341tC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","LU0566484027.USD","ANIP","LU1559883803.SGD","BK4007","BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652427187","title":"ANI Pharmaceuticals intends to appeal rulings in CG Oncology matter","url":"https://stock-news.laohu8.com/highlight/detail?id=2652427187","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652427187?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:40","pubTimestamp":1784234411,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals (ANIP) announced that Judge Sheldon K. Rennie, on July 16, denied ANI’s post-trial motions for a new trial and judgment as a ma...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ani-pharmaceuticals-intends-to-appeal-rulings-in-cg-oncology-matter-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ani-pharmaceuticals-intends-to-appeal-rulings-in-cg-oncology-matter-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4135","LU1559883803.SGD","IE00B64PRP62.GBP","LU0566484027.USD","CGON","IE00BGHQF748.EUR","SBIO","ANIP","CG","BK4139","BK4007","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652422960","title":"ANI Pharma Plans Delaware Supreme Court Appeal in CG Oncology Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2652422960","media":"Reuters","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652422960?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:34","pubTimestamp":1784234069,"startTime":"0","endTime":"0","summary":"ANI Pharma plans Delaware Supreme Court appeal in CG Oncology disputeANI Pharmaceuticals will appeal to the Delaware Supreme Court after a trial judge denied its post-trial motions in a dispute with C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL9M2TVg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","IE00BKPKM429.USD","LU2095319765.USD","SG9999014013.SGD","SG9999014021.USD","IE00B64PRP62.GBP","LU2210150020.SGD","IE00B3QW5Z07.USD","NDAQ","BK4139","BK4112","IE00BN0W2V16.EUR","BK4007","CGON","ANIP","IE00BN0W2T93.GBP","SG9999014005.SGD","BK4585","LU0566484027.USD","BK4588","LU0314104364.USD","IE00BGHQF748.EUR","BCDF","IE00BN0W2W23.USD","LU1559883803.SGD","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651948960","title":"CG Oncology Director James Mulay Disposes of Common Shares Worth $1.82 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2651948960","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651948960?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:15","pubTimestamp":1784060148,"startTime":"0","endTime":"0","summary":"CG Oncology director James Mulay disposes of common shares worth $1.82 millionCG Oncology director James Mulay exercised director stock options for 24,165 common shares at $26.63 on July 10, 2026.Mula","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL6YPf6w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CG Oncology Director James Mulay Disposes of Common Shares Worth $1.82 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651281147","title":"CG Oncology (CGON) In Focus Following Early Trial Results And BLA Timing Questions On Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2651281147","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651281147?lang=en_us&edition=fundamental","pubTime":"2026-07-14 06:24","pubTimestamp":1783981455,"startTime":"0","endTime":"0","summary":"Early trial results and BLA timeline put CG Oncology in focus\nCG Oncology (CGON) is back in the spotlight after positive early Phase II data for cretostimogene grenadenorepvec with gemcitabine and clearer timing for a planned biologics license application in high-risk bladder cancer.\nSee our latest analysis for CG Oncology.\nThe recent early Phase II update and clearer BLA timeline appear to be feeding into sentiment around CG Oncology, with a 30-day share price return of 21.73% and a year to...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/cg-oncology-cgon-in-focus-following-early-trial-results-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/cg-oncology-cgon-in-focus-following-early-trial-results-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CGON","IE00BGHQF748.EUR","BK4135","BK4139","IE00B3QW5Z07.USD","SBIO","IE00B64PRP62.GBP","CG","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650181447","title":"Analysts Offer Insights on Healthcare Companies: aTyr Pharma (ATYR) and CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650181447","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650181447?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:20","pubTimestamp":1783678834,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on aTyr Pharma (ATYR) and CG Oncology, Inc. (CGON) with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-atyr-pharma-atyr-and-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-atyr-pharma-atyr-and-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SBIO","IE00B3QW5Z07.USD","CGON","ATYR","XLV","BK4585","BK4137","HCSG","BK4135","BK4581","LU0029874061.USD","BK4139","CG","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LABU","XBI","BK4588","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648596049","title":"CG Oncology Posts Investor Deck Highlighting Cretostimogene Data in Non-muscle Invasive Bladder Cancer Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2648596049","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648596049?lang=en_us&edition=fundamental","pubTime":"2026-07-01 09:56","pubTimestamp":1782871018,"startTime":"0","endTime":"0","summary":"CG Oncology posts investor deck highlighting cretostimogene data in non-muscle invasive bladder cancer trialsCG Oncology highlighted updated efficacy for cretostimogene in high-risk BCG-unresponsive N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDLbKgj6c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647586716","title":"Top Insider Makes Massive Bet on CG Oncology’s Future","url":"https://stock-news.laohu8.com/highlight/detail?id=2647586716","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647586716?lang=en_us&edition=fundamental","pubTime":"2026-06-30 10:04","pubTimestamp":1782785050,"startTime":"0","endTime":"0","summary":"New insider activity at CG Oncology, Inc. ( ($CGON) ) has taken place on June 29, 2026. Director Brian Guan-Chyun Liu has made a major move in CG O...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-insider-makes-massive-bet-on-cg-oncologys-future-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-insider-makes-massive-bet-on-cg-oncologys-future-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4135","IE00B64PRP62.GBP","CGON","IE00BGHQF748.EUR","CG","BK4139","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647630793","title":"CG Oncology Director Brian Guan-chyun Liu Reports Purchase of $24.81 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2647630793","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647630793?lang=en_us&edition=fundamental","pubTime":"2026-06-30 05:27","pubTimestamp":1782768462,"startTime":"0","endTime":"0","summary":"CG Oncology director Brian Guan-Chyun Liu reports purchase of $24.81 million in common sharesCG Oncology director Brian Guan-Chyun Liu reported an indirect purchase of 371,085 common shares at USD 66.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL2FBvpQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON","BK7093","FPR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646333386","title":"CG Oncology Director Leonard Post Disposes of 5,000 Common Shares Worth $350,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2646333386","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646333386?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:31","pubTimestamp":1782419462,"startTime":"0","endTime":"0","summary":"CG Oncology director Leonard Post disposes of 5,000 common shares worth $350,000CG Oncology director Leonard E. Post sold 5,000 common shares at $70 on June 24, 2026, cutting his direct stake to zero.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL7PKdDW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CG Oncology Director Leonard Post Disposes of 5,000 Common Shares Worth $350,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646506841","title":"CG Oncology 1.15M share Block Trade; price range $66.87-$67.87","url":"https://stock-news.laohu8.com/highlight/detail?id=2646506841","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646506841?lang=en_us&edition=fundamental","pubTime":"2026-06-25 05:45","pubTimestamp":1782337509,"startTime":"0","endTime":"0","summary":"Morgan Stanley is acting as sole book running manager for the offering. Published first on TheFly – the ultimate source for real-time, market-movin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-1-15m-share-block-trade-price-range-66-87-67-87-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-1-15m-share-block-trade-price-range-66-87-67-87-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0971096721.USD","LU1720051017.SGD","LU0314104364.USD","BK4588","LU1244550221.USD","LU0234570918.USD","LU1162221912.USD","LU0320765646.SGD","IE00BGHQF748.EUR","BK4504","IE00B3QW5Z07.USD","BK4127","BK4581","LU2089284900.SGD","LU0390134368.USD","BK4516","CG","BK4139","IE00BZ1G4Q59.USD","LU0158827948.USD","LU2347655156.SGD","LU1989772840.SGD","LU0106261372.USD","LU1244550577.SGD","LU1074936037.SGD","LU0006306889.USD","LU1064131342.USD","BK4135","LU2357305700.SGD","LU2028103732.USD","LU2487616109.SGD","CGON","LU0098860793.USD","LU2089283258.USD","LU1548497426.USD","LU0267386448.USD","LU2271345857.HKD","LU0528227936.USD","DAPP","LU1988902786.USD","LU0210528500.USD","LU1363072403.SGD","LU1989772923.USD","LU0557290698.USD","LU0225283273.USD","LU0912757837.SGD","LU1244550494.USD","LU1791710582.SGD","LU2264538146.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645285184","title":"CG Oncology director Leonard Post disposes of 5,000 shares for $325,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2645285184","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645285184?lang=en_us&edition=fundamental","pubTime":"2026-06-24 04:31","pubTimestamp":1782246662,"startTime":"0","endTime":"0","summary":"CG Oncology director Leonard E. Post sold 5,000 common shares at USD 65 on June 22, 2026.He exercised a director stock option for 5,000 shares at USD 0.6 the same day.Post ended the day with 0 common shares held directly.He reported 111,077 director stock options beneficially owned following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDLbJt7LD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CG Oncology director Leonard Post disposes of 5,000 shares for $325,000","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645092919","title":"Analysts Are Bullish on These Healthcare Stocks: PepGen Inc. (PEPG), CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645092919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645092919?lang=en_us&edition=fundamental","pubTime":"2026-06-21 15:30","pubTimestamp":1782027005,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PepGen Inc. (PEPG) and CG Oncology, Inc. (CGON) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-pepgen-inc-pepg-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-pepgen-inc-pepg-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644798466","title":"CG Oncology director James Mulay disposes of 1,964 common shares worth $118,795.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2644798466","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644798466?lang=en_us&edition=fundamental","pubTime":"2026-06-17 05:07","pubTimestamp":1781644062,"startTime":"0","endTime":"0","summary":"CG Oncology director James Mulay exercised director stock options for 1,964 common shares on June 15.He sold the same 1,964 shares at USD 60.12 each in the same session.His direct common stock position fell to zero following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL3h5nj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CG Oncology director James Mulay disposes of 1,964 common shares worth $118,795.68","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642434021","title":"CG Oncology Shareholders Back Directors and Governance Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2642434021","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642434021?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:19","pubTimestamp":1780953577,"startTime":"0","endTime":"0","summary":"CG Oncology, Inc. ( ($CGON) ) just unveiled an update. On June 4, 2026, CG Oncology, Inc. held its 2026 Annual Meeting of Stockholders, at which sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cg-oncology-shareholders-back-directors-and-governance-proposals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cg-oncology-shareholders-back-directors-and-governance-proposals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4135","BK4139","IE00BGHQF748.EUR","IE00B64PRP62.GBP","CGON","CG","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642443187","title":"CG Oncology shareholders elect Class II directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642443187","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642443187?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:02","pubTimestamp":1780948977,"startTime":"0","endTime":"0","summary":"CG Oncology held its annual shareholder meeting on June 4, 2026.An advisory vote backed the frequency of future shareholder advisory votes on executive pay being held annually.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL10cxP4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641140388","title":"CG Oncology director Leonard Post sells 1,000 shares for $54,500","url":"https://stock-news.laohu8.com/highlight/detail?id=2641140388","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641140388?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:31","pubTimestamp":1780691466,"startTime":"0","endTime":"0","summary":"CG Oncology director Leonard E. Post exercised options for 1,000 shares at USD 0.6 on June 4, 2026.Post sold 1,000 shares at USD 54.5 the same day, ending with 0 shares owned directly.He reported 116,077 director stock options remaining after the exercise.Post also received a new director stock option for 9,354 shares with an exercise price of USD 56.09.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL3y1TN2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CG Oncology director Leonard Post sells 1,000 shares for $54,500","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639168446","title":"CG Oncology to Present at Upcoming Investor Conferences in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2639168446","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639168446?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:05","pubTimestamp":1779998700,"startTime":"0","endTime":"0","summary":"DALLAS, May  28, 2026  (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman, President & Chief Executive Officer, will participate in fireside chat presentat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3303253/0/en/CG-Oncology-to-Present-at-Upcoming-Investor-Conferences-in-June.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2750360997.AUD","LU0942090050.USD","IE0004086264.USD","BK4504","IE00BSNM7G36.USD","LU2237443895.HKD","LU1894683348.USD","BK4533","BK4516","LU0868494617.USD","LU1868837136.USD","LU0251131958.USD","LU2750360641.GBP","LU1804176565.USD","LU1791807156.HKD","CGON","LU1868837300.USD","IE0034235188.USD","LU0106831901.USD","LU1668664300.SGD","LU1868836914.USD","IE0004091025.USD","IE00BGHQF748.EUR","LU2237443549.SGD","LU0345770308.USD","XBI","LABU","BK4552","IE00BFXG1179.USD","LU0048573561.USD","LU0061475181.USD","LU2237443978.SGD","LU2237443622.USD","BK4550","BK4139","LU0868494708.USD","LU1868836757.USD","LU2265009873.SGD","XLV","LU0251142724.SGD","LU0096364046.USD","GSX","BK4135","LU1868836591.USD","BK4585","IE00B19Z3581.USD","LU2237438978.USD","LU2471134523.USD","LU0345770993.USD","CG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638768837","title":"Analysts’ Top Healthcare Picks: Spruce Biosciences (SPRB), CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638768837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638768837?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:40","pubTimestamp":1779885630,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Spruce Biosciences (SPRB) and CG Oncology, Inc. (CGO...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-spruce-biosciences-sprb-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-spruce-biosciences-sprb-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","IE00BGHQF748.EUR","CGON","LABU","BK4139","BK4588","CG","XLV","BK4137","BK4585","HCSG","IE00B64PRP62.GBP","LU0029874061.USD","SPRB","BK4581","BK4135","LU0128526141.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://cgoncology.com;ir.cgoncology.com","stockEarnings":[{"period":"1week","weight":0.0233},{"period":"1month","weight":0.082},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.3217},{"period":"1year","weight":1.7021},{"period":"ytd","weight":0.7129}],"compareEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.034},{"period":"6month","weight":0.071},{"period":"1year","weight":0.1639},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"CG Oncology Inc.","nameEN":"CG Oncology Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CG Oncology Inc.(CGON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CG Oncology Inc.(CGON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CG Oncology Inc.,CGON,CG Oncology Inc.股票,CG Oncology Inc.股票老虎,CG Oncology Inc.股票老虎国际,CG Oncology Inc.行情,CG Oncology Inc.股票行情,CG Oncology Inc.股价,CG Oncology Inc.股市,CG Oncology Inc.股票价格,CG Oncology Inc.股票交易,CG Oncology Inc.股票购买,CG Oncology Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CG Oncology Inc.(CGON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CG Oncology Inc.(CGON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction